common site of pathology, with decreasing incidence at the distal extremity of the lower limb. In our case, only the foot and ankle region was affected, with both feet being affected at different points of time. Recurrence of episodes have been described in the literature, and can affect different anatomical sites. This was the case for our patient, but specifically affected the distal limb on each occasion rather than more common proximal sites. Episodes had been relatively frequent also in our patient, with multiple episodes over the preceding 1ten years -which also appears to be an atypical phenomenon. Due to the location of symptoms at the patient's feet, her recurrent episodes had been essentially misdiagnosed as prolonged gout flares, thus leading to delayed diagnosis. Unfortunately, based on the literature, this is a more common experience in patients with foot involvement due to its lower frequency and nonspecific nature. As such, patients are at risk of persistent bone pain symptoms whichcan affect function and subsequent qualityof life. Key Learning Points: Bone marrow oedema syndrome is a rare condition that can often be missed. Symptoms can be transient in nature with patients not presenting, or being misdiagnosed with alternative conditions. In our described case, the patient's episode was prolonged thus allowing appropriate investigation. Cases are generally managed conservatively, however gradual resolution can take weeks to months to occur. Literature is limited in regarding medical therapy, however use of bisphosphonates has been described and was utilised in this case. Our patient is undergoing continued follow up within the community under the rheumatology team tomonitorher gradual recovery.
tion that can often be missed. Symptoms can be transient in nature with patients not presenting, or being misdiagnosed with alternative conditions. In our described case, the patient's episode was prolonged thus allowing appropriate investigation. Cases are generally managed conservatively, however gradual resolution can take weeks to months to occur. Literature is limited in regarding medical therapy, however use of bisphosphonates has been described and was utilised in this case. Our patient is undergoing continued follow up within the community under the rheumatology team tomonitorher gradual recovery. Disclosure: S. El-Ghazali: None. K. Bhamra: None. A. Khan: None. M. Burden:None. I. Patel: None. Rheumatology, The Dudley Group NHS Foundation Trust, Dudley, UNITED KINGDOM Introduction: A comprehensive medical history is essential in new patient appointments and is constructed from the building blocks of previous medical encounters. But in the same way that a house is built of bricks, a diagnostic conundrum may be solved by pulling strands of the medical history together to make a coherent whole as observed in a rare case of the auto-inflammatory condition Schnitzler syndrome. Case description: A 44-year-old Caucasian woman was referred to the rheumatology department of a district general hospital for rather nonspecific intermittent small joint arthralgia. She reported a progressive, persistent non-pruritic urticarial rash which was spreading from trunk to limbs and which she now felt affected her ability to deliver care as an allied healthcare professional. She disclosed years of drenching night sweats and maintained a slim but stable weight. She saw immunology for the urticarial rash, managed with fexofenadine and levocetirizine with limited benefit. She saw haematology for an IgM monoclonal gammopathy of undetermined significance (MGUS) and remained under their surveillance. In her family history, her grandmother had rheumatoid arthritis, her mother was treated for systemic lupus erythematosus and her son had a selective IgA deficiency. On examination, an extensive urticarial rash was noted over the patient's abdomen, chest and back. There were no findings of a classical inflammatory arthritis. There was a solitary, 1 cm nonpainful lymph node palpable in the left axilla. The patient had mild abdominal tenderness and had been simultaneously referred also for investigations after complaining of breast pain. The patient had a working diagnosis of both MGUS and chronic urticaria but neither fully explained the night sweats or intermittent arthralgia and prompted widening the list of differential diagnoses which for chronic urticaria includes autoimmune urticaria, cholinergic urticaria, cold urticaria, mastocytosis, and periodic fever syndromes including Muckle-Wells syndrome. At the first rheumatology visit, the suspicion was of an (as yet unknown) unifying diagnosis and an internet search of the main symptoms brought up Schnitzler syndrome at the top of the list. A telephone discussion the following day with the National Amyloidosis Centre confirmed that the patient satisfied the Strasbourg criteria for Schnitzler syndrome and prompted an urgent referral. In the meantime, routine investigations were completed in line with the patient's symptoms and history. A bilateral mammogram showed benign and fibrocystic change and enlarged lymph nodes in both axillae.ACT thorax, abdomen andpelvisshowed mildlyenlarged bilateral axillary nodes with no mediastinal or abdomino-pelvic adenopathy and with a normal liver and spleen. An US guided biopsy of an enlarged axillary lymph node showed non-specific benign reactive lymphadenopathy. Immunology showed a marginally raised rheumatoid factor but was negative for anti-nuclear antibody and extractable nuclear antigens, and ferritin, C3, C4 complement levels, C1 inhibitor, lactate dehydrogenase and immunoglobulin E values were all in normal ranges. Paraproteinaemia had been gradually increasing with immunoglobulin M (IgM) >15 g/L at presentation. There were moderately raised inflammatory markers. A punch biopsy of the skin of the mid back showed features consistent with an urticarial vasculitis without fibrinoid necrosis of blood vessels and slides were also sent for review by an international expert in the condition in Strasbourg. While awaiting skin biopsy results, the patient had her first visit to the national centre with a diagnosis of Schnitzler syndrome followed by prescription of the interleukin-1 antagonist anakinra with rapid improvement in urticarial rash and night sweats. The patient has gained weight and is back to being comfortable wearing short sleeved tops. She relies on daily anakinra to keep symptoms at bay and had re-occurrence of rash when she forgot her medication during a weekend away. An autoinflammatory focused genetic screen showed no mutations. She remains under specialist care with a rapid and sustained drop in serum amyloid A protein levels and a slowing down in increase of IgM levels. She still has some persistent sweats. Discussion: Schnitzler syndrome is a rare auto-inflammatory condition first described in 1972 with the index case dying at the age of 88 years. It likely arises from a defect in the innate immune system and manifests as chronic urticaria/IgM(G) gammopathy/arthralgia/raised inflammatory markers. At least 300 cases have been documented worldwide, mostly in adult Caucasians, but the number of identified cases is increasing with greater awareness of the condition. The family history is typically negative for symptoms of Schnitzler syndrome (one case report of a family positive for a monoclonal gammopathy) and there are no known risk factors for the condition. Currently genetic screening typically includes a panel of autoinflammatory genes but no expanded and familial genome wide studies have been reported. The role of interleukin (IL)-1 matured in the inflammasome is important since a daily subcutaneous injection of the IL-1 receptor antagonist anakinra rapidly controls symptoms. The rapid response to anakinra helps confirm the condition but symptoms rapidly return when the drug is stopped. The course of the disease is generally benign but 15-20 % of patients develop a lymphoproliferative disorder prompting examination of lymph nodes and bone marrow and long-term surveillance. Key Learning Points: Pattern recognition works not only when we already know the pattern but equally when there is strong clinical suspicion of one. Schnitzler syndrome is a rare auto-inflammatory condition that typically responds rapidly to IL-1 antagonists with significant improvement in quality of life. No known risk factors for Schnitzler syndrome are known but familial clustering of both auto-immune and autoinflammatory conditions (as in this case) should be explored in more detail. We aim to present a rare case of osseous sarcoid in a 57 year old presenting with multiple sclerotic lesions of the axial skeleton with minimalinvolvement of other systems. Case description: This 57 year old male initially presented in June 2016 to the neurosurgery department with acute onset of severe neck pain and brachialgia, following a twisting injury as part of his duties as a village care taker. A CT of the cervical spine demonstrated a C6/C7 disc prolapse and he was listed for adiscectomy. His past medical, family and drug history were unremarkable. He was a non-smoker who drank limited amounts of alcohol. In the past he had worked in an occupation that involved disposing of dead animals and exposure to animal faeces as part of his occupation as a refuse collector. Whilst awaiting this procedure, approximately a month later he developed severe subacute lower back pain which was non-inflammatory in nature but radiated down both legs. This prompted his general practitioner to organise an MRI of lumbo-sacral spine. Prior to the MRI being reported, this imaging was reviewed incidentally at a neurosurgical preoperative clinic and it appeared to demonstrate multiple sclerotic lesions in thoracic and cervical spine suggestive of metastatic disease. Given the above findings, he was referred urgently to the cancer of unknown primary multi-disciplinary team for further assessment. Urinary Bence Jones protein and prostate-specific antigen were normal at this time. CRP was 2.4mg/L and the adjusted calcium was 2.34mmol/L, both also within normal limits. A CT thorax-abdomen and pelvis in January 2017 did not identify a primary malignancy but it did demonstrate indeterminate small pulmonary nodules and mediastinal lymphadenopathy. A bone scan did not show any uptake, and an attempted biopsy of the L4 vertebra was unsuccessful due to severe pain on contact with the periosteum. Further to this, a mediastinal node biopsy was organised via endoscopic ultrasound. In the interim, the gentleman had a PET-CT which showed
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